Publications

1. Atherton PJ, Halyard MY, Sloan JA, Miller RC, Deming RL, Tai TH, Stien KJ, Martenson JA Jr. Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CA. Support Care Cancer. 2013 Apr; 21(4):1193-9. Epub 2012 Nov 15. 2283810
   View PubMed
2. Patel SH, Hinni ML, Hayden RE, Wong WW, Dueck AC, Zarka MA, Curtis KK, Halyard MY. Transoral laser microsurgery followed by radiation therapy for oropharyngeal tumors: The mayo clinic arizona experience. Head Neck. 2013 Mar 26. [Epub ahead of print] 2313187
   View PubMed
3. Tarantola TI, Vallow LA, Halyard MY, Weenig RH, Warschaw KE, Grotz TE, Jakub JW, Roenigk RK, Brewer JD, Weaver AL, Otley CC. Prognostic factors in Merkel cell carcinoma: analysis of 240 cases. J Am Acad Dermatol. 2013 Mar; 68(3):425-32. Epub 2012 Nov 27. 2287750
   View PubMed
4. Tarantola TI, Vallow LA, Halyard MY, Weenig RH, Warschaw KE, Weaver AL, Roenigk RK, Brewer JD, Otley CC. Unknown primary Merkel cell carcinoma: 23 new cases and a review. J Am Acad Dermatol. 2013 Mar; 68(3):433-40. Epub 2012 Nov 19. 2285783
   View PubMed
5. Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, Hess R, Miller DM, Reeve BB, Santana M. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res. 2012 Oct; 21(8):1305-14. Epub 2011 Nov 03. 2281281
   View PubMed
6. Halyard MY, Wasif N, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Horst KC, Moran MS, MacDonald SM, Haffty BG, Expert Panel on Radiation Oncology-Breast:. ACR Appropriateness Criteria(R) local-regional recurrence (LR) and salvage surgery: breast cancer. Am J Clin Oncol. 2012 Apr; 35(2):178-82. 2235354
   View PubMed
7. Moran MS, Bai HX, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY, Horst KC, MacDonald SM, Haffty BG, American College of Radiology Breast Expert Panel. ACR appropriateness criteria((R)) ductal carcinoma in situ. Breast J. 2012 Jan-Feb; 18(1):8-15. Epub 2011 Nov 23. 2273658
   View PubMed
8. Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, Hess R, Miller DM, Reeve BB, Santana M. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res. 2011 Nov 3. 2205135
   
9. Macdonald SM, Harris EE, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY, Horst KC, Moran MS, Haffty BG. ACR appropriateness criteria(R) locally advanced breast cancer. Breast J. 2011 Nov-Dec; 17(6):579-85. Epub 2011 Sep 12. 2189403
   View PubMed
10. Peters DE, Halyard MY, Casale SA, Mayer AP, Viggiano TR. Effectively Integrating Medical Staff into a Multispecialty Group Practice: Results from Mayo Clinic. American Medical Group Association - Group Practice Journal. 2011 Oct. 2201562
    
11. Halyard MY. The use of real-time patient-reported outcomes and quality-of-life data in oncology clinical practice. Expert Rev Pharmacoecon Outcomes Res. 2011 Oct; 11(5):561-70. 2196868
    View PubMed
12. Bellon JR, Harris EE, Arthur DW, Bailey L, Carey L, Goyal S, Halyard MY, Horst KC, Moran MS, MacDonald SM, Haffty BG, American College of Radiology. ACR Appropriateness Criteria(R) conservative surgery and radiation--stage I and II breast carcinoma: expert panel on radiation oncology: breast. Breast J. 2011 Sep-Oct; 17(5):448-55. Epub 2011 Jul 25. 2256165
    View PubMed
13. Moran MS, Harrison XB, Harris EER, Arthur DW, Bailey L, Bellon JR, Carey L, Goyal S, Halyard MY, Horst KC, MacDonald SM, Haffty BG. ACR Appropriateness Criteria: Ductal Carcinoma in Situ. The Breast Journal. 2011:1-8. 2209099
    
14. Barsevick A, Frost M, Zwinderman A, Hall P, Halyard M, GENEQOL Consortium. I'm so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res. 2010 Dec; 19(10):1419-27. Epub 2010 Oct 16. 2206846
    View PubMed
15. Sprangers MA, Sloan JA, Barsevick A, Chauhan C, Dueck AC, Raat H, Shi Q, Van Noorden CJ, GENEQOL Consortium. Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Qual Life Res. 2010 Dec; 19(10):1395-403. Epub 2010 Oct 14. 2206665
    View PubMed
16. Shi Q Cleeland CS Klepstad P Miaskowski C Pedersen NL, GeneQOL Consortium. Biological pathways and genetic variables involved in pain. Qual Life Res Feb;20(1):151-2. 2010 Dec; 19(10):1407-17 Epub 2010 Sep. 2191121
    
17. Sprangers MAG, Bartels M, Veenhoven R, Baas F, Martin NG, Mosing M, Movsas B, Ropka ME, Shinozaki G, Swaab D, The GENEQOL Consortium. Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states. Qual Life Res. 2010 Apr 24. [Epub ahead of print] 1999180
    
18. Pockaj BA, Degnim AC, Boughey JC, Gray RJ, McLaughlin SA, Dueck AC, Perez EA, Halyard MY, Frost MH, Cheville AL, Sloan JA. Quality of life after breast cancer surgery: What have we learned and where should we go next? J Surg Oncol. 2009 Jun 1; 99(7):447-55. 1940710
    View PubMed
19. Halyard MY, Pisansky TM, Dueck AC, Suman V, Pierce L, Solin L, Marks L, Davidson N, Martino S, Kaufman P, Kutteh L, Dakhil SR, Perez EA. Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831. J Clin Oncol. 2009 Jun 1; 27(16):2638-44. Epub 2009 Apr 06. 1935365
    View PubMed
20. Sprangers MA, Sloan JA, Veenhoven R, Cleeland CS, Halyard MY, Abertnethy AP, Baas F, Barsevick AM, Bartels M, Boomsma DI, Chauhan C, Dueck AC, Frost MH, Hall P, Klepstad P, Martin NG, Miaskowski C, Mosing M, Movsas B, Van Noorden CJ, Patrick DL, Pedersen The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet. 2009 Jun; 12(3):301-11. 1951162
    View PubMed
21. Tondato F, Ng DW, Srivathsan K, Altemose GT, Halyard MY, Scott LR. Radiotherapy-induced pacemaker and implantable cardioverter defibrillator malfunction. Expert Rev Med Devices. 2009 May; 6(3):243-9. 1940708
    View PubMed
22. Halyard M, Pisansky T, Dueck A, Pierce L, Solin L, Marks L, Davidson N, Martino S, Kaufman P, Kutteh L, Dakhil S, Perez E. Radiotherapy and Adjuvant Trastuzumab in Stage I-IIA Breast Cancer: Tolerability and Adverse Event Data From the North Central Cancer Treatment Group Phase I Trial N9831. J Clin Oncol. 2009; 27:2638-44. 2010933
    View PubMed
23. Martenson JA, Halyard MY, Sloan JA, Proulx GM, Miller RC, Deming RL, Dick SJ, Johnson HA, Tai TH, Zhu AW, Keit J, Stien KJ, Atherton PJ. Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA. J Clin Oncol. 2008 Nov 10; 26(32):5248-53. Epub 2008 Sep 02. 1903996
    View PubMed
24. Carpenter S, Fraser J, Fleming M, Gray R, Halyard M, Pockaj B. Optimal treatment of multiple ipsilateral primary breast cancers. Am J Surg. 2008 Oct; 196(4):530-6. 1904634
    View PubMed
25. Halyard MY, Ferrans CE. Quality-of-Life assessment for routine oncology clinical practice. J Support Oncol. 2008 May-Jun; 6(5):221-9, 233. 1898891
    View PubMed
26. Valderas JM, Kotzeva A, Espallargues M, Guyatt G, Ferrans CE, Halyard MY, Revicki DA, Symonds T, Parada A, Alonso J. The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res. 2008 Mar; 17(2):179-93. Epub 2008 Jan 04. 1898896
    View PubMed
27. Sloan JA, Halyard MY, Frost MH, Dueck AC, Teschendorf B, Rothman ML. The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes. Value Health. 2007 Nov-Dec; 10(Suppl 2):S59-63. 1909202
    View PubMed
28. Guyatt GH, Ferrans CE, Halyard MY, Revicki DA, Symonds TL, Varricchio CG, Kotzeva A, Valderas JM, Alonso JL, Clinical Significance Consensus Meeting Group. Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice. Mayo Clin Proc. 2007 Oct; 82(10):1229-39. 1844626
    View PubMed
29. Vora SA, Wong WW, Schild SE, Ezzell GA, Halyard MY. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1053-8. Epub 2007 Mar 29. 1832958
    View PubMed
30. Halyard MY, Jatoi A, Sloan JA, Bearden JD 3rd, Vora SA, Atherton PJ, Perez EA, Soori G, Zalduendo AC, Zhu A, Stella PJ, Loprinzi CL. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys. 2007 Apr 1; 67(5):1318-22. 1818768
    View PubMed
31. Snyder CF, Watson ME, Jackson ME, Cella D, Halyard MY. Patient-Reported Outcome Instrument Selection: Designing a Measurement Strategy. The Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group Val Health. 2007; 10:S76-S85. 1858605
    
32. Halyard MY, Frost MH, Dueck A, Sloan JA. Is the use of QOL data really any different than other medical testing? Curr Probl Cancer. 2006 Nov-Dec; 30(6):261-71. 1799622
    View PubMed
33. Halyard MY, Frost MH, Dueck A. Integrating QOL assessments for clinical and research purposes. Curr Probl Cancer. 2006 Nov-Dec; 30(6):319-30. 1799627
    View PubMed
34. Sloan JA, Frost MH, Berzon R, Dueck A, Guyatt G, Moinpour C, Sprangers M, Ferrans C, Cella D, Clinical Significance Consensus Meeting Group. The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer. 2006 Oct; 14(10):988-98. Epub 2006 Jun 23. 1909725
    View PubMed
35. Halyard M, Sloan J. Applying QOL Assessments: Are solutions for QOL different than other medical testing? Curr Probl Cancer. 2006. 1738867
    
36. Brown PD, Foote RL, McLaughlin MP, Halyard MY, Ballman KV, Collie AC, Miller RC, Flemming KD, Hallett JW. A historical prospective cohort study of carotid artery stenosis after radiotherapy for head and neck malignancies. Int J Radiat Oncol Biol Phys. 2005 Dec 1; 63(5):1361-7. Epub 2005 Sep 19. 1736627
    View PubMed
37. Morrell RM, Halyard MY, Schild SE, Ali MS, Gunderson LL, Pockaj BA. Breast cancer - Related lymphedema. Mayo Clin Proc. 2005 Nov; 80(11):1480-4. 1733748
    View PubMed
38. Stearns L, Boortz-Marx R, Du Pen S, Friehs G, Gordon M, Halyard M, Herbst L, Kiser J. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices. J Support Oncol. 2005 Nov-Dec; 3(6):399-408. 1742749
    View PubMed
39. Schild SE, Wong WW, Vora SA, Halyard MY, Northfelt DW, Kogut HL, Wheeler RH. The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005 Aug 1; 62(5):1432-7. 1726757
    View PubMed
40. Wong WW, Schild SE, Vora SA, Halyard MY. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Sep 1; 60(1):24-9. 1665796
    View PubMed
41. Gray RJ, Forstner-Barthell AW, Pockaj BA, Schild SE, Halyard MY. Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients, with previous implant breast augmentation. Am J Surg. 2004 Aug; 188(2):122-5. 1653836
    View PubMed
42. Halyard MY, McCombs KE, Wong WW, Buchel EW, Pockaj BA, Vora SA, Gray RJ, Schild SE. Acute and chronic results of adjuvant radiotherapy after mastectomy and Transverse Rectus Abdominis Myocutaneous (TRAM) flap reconstruction for breast cancer. Am J Clin Oncol. 2004 Aug; 27(4):389-94. 1662237
    View PubMed
43. Halyard MY, McElrath MF, Abbott DL, Bour TC, Anderson JA. Building values from the ground up: the opening of the Mayo Clinic Hospital: building a workforce that fosters the organizational culture. Group Pract J. 2003; 52(9):9-11. 1638947
    View PubMed
44. Schild SE, Wong WW, Vora SA, Halyard MY, Wheeler RH. Phase I study of hyperfractionated accelerated radiotherapy and escalating doses of daily cisplatin for patients with locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002 Nov 1; 54(3):729-34. 1316716
    View PubMed
45. Wong WW, Schild SE, Halyard MY, Schomberg PJ. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience. J Surg Oncol. 2002 May; 80(1):19-25; discussion 26. 1315651
    View PubMed
46. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, Halyard MY, Pruthi S, Novotny PJ, Rummans TA. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol. 2002 Mar 15; 20(6):1578-83. 1315437
    View PubMed
47. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, Halyard MY, Pruthi S. Novotny PJ, Rumman TA. Phase III evaluation of fluoxetine for treatment of hot flashes J Clin Oncol. 2002; 20(6):1578-83. 1689405
    
48. Schomberg PJ, Shanahan TG, Ingle JN, Donohue JH, Kuske RR, Sternfeld WC, Wold L, Cha SS, Petersen IA, Brindle JS, Halyard MY, Bollinger JW, Hawkins R, Pisansky TM. Accelerated hyperfractionation radiation therapy after lumpectomy and axillary lymph node dissection in patients with stage I or II breast cancer: pilot study. Radiology. 1997 Feb; 202(2):565-9. 101596
    View PubMed
49. Halyard MY, Camoriano JK, Culligan JA, Weiland LH, Allen MS, Pluth JR, Pairolero PC. Malignant fibrous histiocytoma of the lung. Report of four cases and review of the literature. Cancer. 1996 Dec 15; 78(12):2492-7. 1027612
    View PubMed
50. Schild SE, Buskirk SJ, Wong WW, Halyard MY, Swanson SK, Novicki DE, Ferrigni RG. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J Urol. 1996 Nov; 156(5):1725-9. 1027179
    View PubMed
51. Halyard MY, Grado GL, Schomberg PJ, Weaver AL, Grant CS, Pisansky TM. Conservative therapy of breast cancer. The Mayo Clinic experience. Am J Clin Oncol. 1996 Oct; 19(5):445-50. 97814
    View PubMed
52. Halyard MY, Cornella JL, Grado GL, Rizzo NR. Prolonged amenorrhea associated with total nodal irradiation for Hodgkin's disease. J Natl Med Assoc. 1996 Jun; 88(6):391-3. 1026347
    View PubMed
53. Schild SE, Wong WW, Grado GL, Halyard MY, Novicki DE, Swanson SK, Larson TR, Ferrigni RG. The results of radical retropubic prostatectomy and adjuvant therapy for pathologic stage c prostate cancer. Int J Radiat Oncol Biol Phys. 1996 Feb 1; 34(3):535-41. 1025987
    View PubMed
54. Pisansky TM, Halyard MY, Weaver AL, Donohue JH, Grado GL, Grant CS, Hartmann LC, Ingle JN, Schomberg PJ, Wold LE. Breast conservation therapy for invasive breast cancer: a review of prior trials and the Mayo Clinic experience. Mayo Clin Proc. 1994 Jun; 69(6):515-24. 1032029
    View PubMed
55. Schamadan JL, Covalciuc MA, Halyard MY, Trump DS, Whysong GL. Cancer in professional firefighters. Arizona Study Commission Report. 1992 Feb. 1689396
    
56. Tuckson WB, Goldson AL, Ashayeri E, Halyard M, DeWitty RL, Leffall LD. Intraoperative radiotherapy for patients with carcinoma of the pancreas: the Howard University Hospital experience 1978-1986. Ann Surg. 1988; 207:648-54. 1689395
    View PubMed
57. Ashayeri EA, Halyard MY, Goldson A, et al. The first simultaneous intraoperative hyperthermia and radiotherapy procedure: dog experiment and technique. J Nat Med Assoc. 1987; 79:619-24. 1689394
    
58. Collier-Manning JD, Ashayeri EA, Goldson AL, Halyard MY, et al. The use of intraoperative radiotherapy and external beam therapy in the management of desmoid tumors. J Nat Med Assoc. 1986; 78:893-5. 1689393